Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study

Diabetes

Volumn 51, Issue 4, 2002, Pages 1256-1262

  Peila, Rita ^a   Rodriguez, Beatriz L ^b   Launer, Lenore J ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

AGED; AGING; ALLELE; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; GENETIC ASSOCIATION; GLUCOSE TOLERANCE TEST; HIPPOCAMPUS; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MULTIINFARCT DEMENTIA; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL ANALYSIS; VASCULAR AMYLOIDOSIS;

EID: 0036227542     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.4.1256     Document Type: Article

References (50)

1. The impact of diabetes on the CNS
2. Diabetes mellitus and cerebral vascular disease
3. Cerebrovascular disorders in patients with diabetes mellitus
4. Alzheimer's disease-Synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts
5. Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein e4 phenotype: Cross sectional population based study
6. Risk of dementia among persons with diabetes mellitus: A population-based cohort study
7. Diabetes mellitus and the risk of dementia
8. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease
9. Vascular dementia: Incidence and risk factors in the Canadian study of health and aging
10. Modulation of plasma triglyceride levels by apoE phenotype: A meta-analysis
11. Incidence, natural history, and risk factors in lacunar infarction
12. Diabetes as a risk factor for stroke: A population perspective
13. Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects
14. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: Demographic, physical, dietary and biochemical characteristics
15. Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia Aging Study
16. The Cognitive Abilities Screening Instrument (CASI): A practical test for cross-cultural epidemiological study studies of dementia
17. Screening for dementia in the community in cross-national studies: Comparison between the Cognitive Avilities Screeinig Instrument and the Mini-Mental State Examination
18. APOE-epsilon4 predicts incident AD in Japanese-American men: The Honolulu-Asia Aging study
19. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services task force on Alzheimer's disease
20. Criteria for the diagnosis of ischemic vascular dementia proposed by the state of California Alzheimer's Disease Diagnostic and Treatment Centers
21. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop
22. Accuracy of Clinical Criteria for AD in the Honolulu-Asia Aging Study, A population based study
23. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease
24. Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: The HAAS
25. Association between cerebral amyloid angiopathy and dementia: The Honolulu-Asia Aging study
26. Cerebral amyloid angiopathy: Incidence and complications in the aging brain. II. The distribution of vascular amyloid changes
27. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
28. Diabetes in older adults: Comparison of 1997 American diabetes association classification of diabetes mellitus with 1985 WHO classification
29. Alterations in glucose metabolism in patients with Alzheimer's disease
30. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI
31. Apolipoprotein E4 allele and Alzheimer disease: Examination of allelic association and effect on age at onset in both early- and late-onset cases
32. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: Introduction
33. Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index
34. Gene-environment interaction: Definitions and study designs
35. Epidemiologic programs for computers and calculators: Use of Poisson regression models in estimating incidence rates and ratios
36. Longitudinal association of vascular and Alzheimer's dementias, diabetes, and glucose tolerance
37. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: The Third National Health and Nutrition Examination Survey, 1988-1994
38. Pathological correlates to late-onset dementia in a multicenter, community-based population in England and Wales
39. Cerebrovascular dementia: Pathophysiology, diagnosis and treatment
40. Brain infarction and the clinical expression of Alzheimer disease: The Nun Study
41. Alzheimer's disease: Insolubility of partially purified paired helical filaments in sodium dodecyl sulfate and urea
42. Advanced Maillard reaction end products are associated with Alzheimer disease pathology
43. Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of beta-amyloid peptide
44. Glycation and microglial reaction in lesions of Alzheimer's disease
45. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases
46. Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments
47. The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's disease
48. Enhanced binding of advanced glycation endproducts (AGE) by the ApoE4 isoform links the mechanism of plaque deposition in Alzheimer's disease